Common Contracts
3 similar Supply Agreement contracts by Citius Pharmaceuticals, Inc.
EX-10.10 7 ctxr_ex1010.htm SUPRENZA QUALITY AGREEMENT EXECUTION COPY SUPPLY AGREEMENTSupply Agreement • May 5th, 2020 • New York
THIS SUPPLY AGREEMENT (this “Agreement”) is made and entered into effective as of the 15th day of November, 2011 (the “Effective Date”) by and between Prenzamax, LLC, a Delaware limited liability company having a place of business at 11 Commerce Drive, Suite 100, Cranford, New Jersey, U.S.A. 07016 (“Company”) and Alpex Pharma S.A., a Switzerland Societe Anonyme having its principal offices at Mezzovico, Switzerland (“Alpex”) (and, for the purposes of the guaranty set forth in Section 12.12 only, Akrimax Pharmaceuticals, LLC (“Akrimax”)).
SUPPLY AGREEMENTSupply Agreement • November 4th, 2015 • Citius Pharmaceuticals, Inc. • Motor vehicle parts & accessories • New York
THIS SUPPLY AGREEMENT (this "Agreement") is made and entered into effective as of the 15th day of November, 2011 (the "Effective Date") by and between Prenzamax, LLC, a Delaware limited liability company having a place of business at 11 Commerce Drive, Suite 100, Cranford, New Jersey, U.S.A. 07016 ("Company") and Alpex Pharma S.A., a Switzerland Societe Anonyme having its principal offices at Mezzovico, Switzerland ("Alpex") (and, for the purposes of the guaranty set forth in Section 12.12 only, Akrimax Pharmaceuticals, LLC ("Akrimax")).
SUPPLY AGREEMENTSupply Agreement • October 16th, 2015 • Citius Pharmaceuticals, Inc. • Motor vehicle parts & accessories • New York
THIS SUPPLY AGREEMENT (this “Agreement”) is made and entered into effective as of the 15th day of November, 2011 (the “Effective Date”) by and between Prenzamax, LLC, a Delaware limited liability company having a place of business at 11 Commerce Drive, Suite 100, Cranford, New Jersey, U.S.A. 07016 (“Company”) and Alpex Pharma S.A., a Switzerland Societe Anonyme having its principal offices at Mezzovico, Switzerland (“Alpex”) (and, for the purposes of the guaranty set forth in Section 12.12 only, Akrimax Pharmaceuticals, LLC (“Akrimax”)).
